Fri, Jul 3, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index Gains 11.21% in 2013; Equity Short Bias Index Suffers Record Loss of 27.15%

Wednesday, January 15, 2014
Opalesque Industry Update - Hedge funds gained 1.23% in December, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index gained 11.21% in 2013.

“The US Fed announced in December that it would reduce Quantitative Easing purchases from $85 billion to $75 billion per month, and assured market participants that until certain growth rates and unemployment levels were achieved, interest rates would remain low,” says Sol Waksman, founder and president of BarclayHedge.

“Equity prices in the US and Europe rallied on the news and the S&P 500 reached a record high on the final trading day of the year."

Overall, 17 of Barclay’s 18 hedge fund indices had gains in December. The Barclay Technology Index gained 2.05%, Pacific Rim Equities were up 2.05%, Equity Long Bias gained 1.98%, the Healthcare & Biotechnology Index was up 1.91%, Equity Long/Short rose 1.72%, and Distressed Securities added 0.97%.

The leading hedge fund index in 2013 was Healthcare & Biotechnology, which gained 28.98%. Pacific Rim Equities were up 23.14%, Equity Long Bias Index returned 21.52%, and Distressed Securities gained 16.62% for the year.

The Equity Short Bias Index fell 2.46% in December, and was the only hedge fund strategy with a loss in 2013. Short Bias ended the year 27.15% in the red, surpassing last year’s record loss of 24.12%.

“The S&P 500 had its best year since 1997 when it gained 33.38 percent,” says Waksman. “For traders on the short side of the market, swimming against a strong current can be treacherous.”

The Barclay Fund of Funds Index gained 1.08% in December, and was up 8.46% in 2013.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds panic over Greece[more]

    Komfie Manalo, Opalesque Asia: Some investors are in panic mode as Greek Prime Minister Alexis Tsipras announced Sunday night that the banks and the stock market would be closed Monday, said

 

banner